| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 60.1 | 41.2 | 47.1 |
| Other income | 0.2 | 0.1 | 0.4 |
| Total income | 60.3 | 41.3 | 47.6 |
| Profit before exceptional items & tax | 5.3 | 3.4 | 8.6 |
| Profit before tax | 5.3 | 3.4 | 8.6 |
| Net profit | 3.3 | 2.4 | 6.1 |
| Operating margin | 8.8% | 8.2% | 18.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -45.90% |
|---|---|
| Net profit, quarter on quarter | +37.50% |
| Revenue, year on year | +27.60% |
Source
Read the filing ↗
NSE results filing, NSE: SOTAC. Figures extracted from the filing.
More from Sotac Pharmaceuticals Limited
All →
18:33 IST
NSE
Dividend
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
18:23 IST
NSE
Annual General Meeting
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
18:48 IST
NSE
Board Meeting Outcome
Sotac Pharmaceuticals Board Meeting Outcome
Sotac Pharmaceuticals' board approved the 11th AGM for September 30, 2026, and recommended a dividend of Rs. 0.20 per share.